These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
636 related articles for article (PubMed ID: 11308992)
1. Sex hormone-binding globulin as a marker of the effect of hormonal treatment in Turner's syndrome. Hampl R; Snajderova M; Lebl J; Lisa L; Dvorakova M; Hill M; Sulcova J; Starka L Endocr Regul; 2001 Mar; 35(1):17-24. PubMed ID: 11308992 [TBL] [Abstract][Full Text] [Related]
2. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause. Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974 [TBL] [Abstract][Full Text] [Related]
4. Insulin, insulin-like growth factor-binding protein-1, and sex hormone-binding globulin in patients with Turner's syndrome: course over age in untreated patients and effect of therapy with growth hormone alone and in combination with oxandrolone. Haeusler G; Schmitt K; Blümel P; Plöchl E; Waldhör T; Frisch H J Clin Endocrinol Metab; 1996 Feb; 81(2):536-41. PubMed ID: 8636264 [TBL] [Abstract][Full Text] [Related]
5. Effects of long-term growth hormone therapy on adrenal steroidogenesis in Turner syndrome. Balducci R; Toscano V; Larizza D; Mangiantini A; Galasso C; Municchi G; Di Rito A; Picone S; Boscherini B Horm Res; 1998; 49(5):210-5. PubMed ID: 9568804 [TBL] [Abstract][Full Text] [Related]
6. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol. Gravholt CH; Naeraa RW; Fisker S; Christiansen JS J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336 [TBL] [Abstract][Full Text] [Related]
7. [[Low birth weight, adrenal and sex hormones and their correlation with carbohydrate metabolism and cardiovascular physiology, investigated in young adulthood] ]. Szathmári M; Reusz G; Tulassay T Orv Hetil; 2000 Sep; 141(36):1967-73. PubMed ID: 11031833 [TBL] [Abstract][Full Text] [Related]
8. [Role of the steroids, SHBG, IGF-1, IGF BP-3 and growth hormone in glucose metabolism disorders during long-term treatment with low doses of glucocorticoids]. Vondra K; Hampl R; Nĕmcová D; Hill M; Hoza J; Kot'átková A; Stárka L; Vrbíková J; Zamrazil V Cas Lek Cesk; 2002 Feb; 141(3):89-95. PubMed ID: 11925670 [TBL] [Abstract][Full Text] [Related]
9. SHBG, testosterone, androstenedione, 17-OH-Progesterone plasma levels in PCO affected women treated with a triphasic oral contraceptive. Negri P; Agnello G; Borghesani F; Tomain L; Minisci N; D'Errico G; Cavallini AR Acta Eur Fertil; 1987; 18(6):375-80. PubMed ID: 3454501 [TBL] [Abstract][Full Text] [Related]
10. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment. Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of plasma androgen and estrogen concentrations in ferrets with hyperadrenocorticism. Rosenthal KL; Peterson ME J Am Vet Med Assoc; 1996 Sep; 209(6):1097-102. PubMed ID: 8800255 [TBL] [Abstract][Full Text] [Related]
12. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. Vermeulen A; Kaufman JM; Giagulli VA J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841 [TBL] [Abstract][Full Text] [Related]
13. Reference intervals for testosterone, androstenedione and SHBG levels in healthy females and males from birth until old age. Elmlinger MW; Kühnel W; Wormstall H; Döller PC Clin Lab; 2005; 51(11-12):625-32. PubMed ID: 16329620 [TBL] [Abstract][Full Text] [Related]
14. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene. Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer. De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871 [TBL] [Abstract][Full Text] [Related]
16. Sex steroid hormones in primary Sjögren's syndrome. Brennan MT; Sankar V; Leakan RA; Grisius MM; Collins MT; Fox PC; Baum BJ; Pillemer SR J Rheumatol; 2003 Jun; 30(6):1267-71. PubMed ID: 12784401 [TBL] [Abstract][Full Text] [Related]
17. Adrenal plasma steroid relations in glucocorticoid-naïve premenopausal rheumatoid arthritis patients during insulin-induced hypoglycemia test compared to matched normal control females. Imrich R; Vigas M; Rovensky J; Aldag JC; Masi AT Endocr Regul; 2009 Apr; 43(2):65-73. PubMed ID: 19856711 [TBL] [Abstract][Full Text] [Related]
18. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status. Gravholt CH; Svenstrup B; Bennett P; Sandahl Christiansen J Clin Endocrinol (Oxf); 1999 Jun; 50(6):791-800. PubMed ID: 10468952 [TBL] [Abstract][Full Text] [Related]